Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Advances in Neurobiology.
Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression.
Demyelinating diseases in Asia.
How Fatigue Influences Exercise Participation in Men With Multiple Sclerosis.
Regulation of oligodendrocyte precursor maintenance by chondroitin sulphate glycosaminoglycans.
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients.
Deep morphea induced by interferon-β1b injection.
Therapy of NMO spectrum disorders.
CNS myelin structural modification induced in vitro by phospholipases A2.
Health-related quality of life in multiple sclerosis: role of cognitive appraisals of self, illness and treatment.
Influence of Formal Education on Cognitive Reserve in Patients with Multiple Sclerosis.
Transdermal immunotherapy: Past, present and future.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
A Novel Asp121Asn Mutation of Myelin Protein Zero Is Associated with Late-Onset Axonal Charcot-Marie-Tooth Disease, Hearing Loss and Pupil Abnormalities.
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.
Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy.
The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.
Fatal herpes encephalitis in a patient with small cell lung cancer following prophylactic cranial radiation - a case report with review of literature.
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
Patterns Of Use Of Tests To Monitor Disease Activity Among Patients Currently Treated For Relapsing Remitting Multiple Sclerosis (Rrms) In Europe.
Clinical perspectives of TRAIL: insights into central nervous system disorders.
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Antibody therapies in CNS diseases.
Positive association of vitamin d receptor gene variations with multiple sclerosis in South East Iranian population.
Pages
« first
‹ previous
…
717
718
719
720
721
722
723
724
725
…
next ›
last »